Cargando…
Risk of Fetal Death after Treatment with Antipsychotic Medications during Pregnancy
BACKGROUND: Antipsychotic medications are increasingly used during pregnancy. Nevertheless, fetal risks are still not fully studied. It is currently unclear whether the antipsychotic treatment might induce a higher risk of fetal death. We aimed to determine if use of antipsychotic medication during...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4498617/ https://www.ncbi.nlm.nih.gov/pubmed/26162087 http://dx.doi.org/10.1371/journal.pone.0132280 |
_version_ | 1782380646489915392 |
---|---|
author | Sørensen, Merete Juul Kjaersgaard, Maiken Ina Siegismund Pedersen, Henrik Søndergaard Vestergaard, Mogens Christensen, Jacob Olsen, Jørn Parner, Erik Pedersen, Lars Henning Bech, Bodil Hammer |
author_facet | Sørensen, Merete Juul Kjaersgaard, Maiken Ina Siegismund Pedersen, Henrik Søndergaard Vestergaard, Mogens Christensen, Jacob Olsen, Jørn Parner, Erik Pedersen, Lars Henning Bech, Bodil Hammer |
author_sort | Sørensen, Merete Juul |
collection | PubMed |
description | BACKGROUND: Antipsychotic medications are increasingly used during pregnancy. Nevertheless, fetal risks are still not fully studied. It is currently unclear whether the antipsychotic treatment might induce a higher risk of fetal death. We aimed to determine if use of antipsychotic medication during pregnancy is associated with an increased risk of spontaneous abortion or stillbirth. METHODS: In a historical cohort study, we identified all clinically recognized pregnancies registered in the nationwide Danish registries from 1997 to 2008 (N = 1,005,319). Exposure was defined as any prescription of antipsychotic medications redeemed by the pregnant women during the exposure window, and recorded in the Danish National Prescription Register. Outcome was defined as any spontaneous abortion or stillbirth recorded in the Danish National Hospital Register and the Danish Medical Birth Register respectively. RESULTS: Women exposed to antipsychotic medications during pregnancy had a 34% higher risk of spontaneous abortion (adjusted relative risk = 1.34; 95% confidence interval = 1.22; 1.46) compared to unexposed women, but a similar risk compared to women exposed prior to (but not during) pregnancy (adjusted relative risk = 1.04; 95% confidence interval = 0.93; 1.17). The risk of spontaneous abortion was not increased in exposed pregnancies when compared to unexposed pregnancies in the same women (adjusted hazard ratio = 1.11; 95% CI = 0.94; 1.31). A twofold higher risk of stillbirth was found in women exposed to antipsychotic medications compared with unexposed women (relative risk = 2.27; 95% confidence interval = 1.45; 3.55) and compared with women exposed only prior to pregnancy (relative risk = 2.06; 95% confidence interval = 1.01; 4.19). CONCLUSIONS: The increased risk of spontaneous abortion found in women treated with antipsychotic medications during pregnancy is most likely due to confounding factors. The risk of stillbirth was twofold higher in pregnancies exposed to antipsychotic medication during pregnancy. Treatment with antipsychotic medications during pregnancy requires careful consideration. |
format | Online Article Text |
id | pubmed-4498617 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-44986172015-07-17 Risk of Fetal Death after Treatment with Antipsychotic Medications during Pregnancy Sørensen, Merete Juul Kjaersgaard, Maiken Ina Siegismund Pedersen, Henrik Søndergaard Vestergaard, Mogens Christensen, Jacob Olsen, Jørn Parner, Erik Pedersen, Lars Henning Bech, Bodil Hammer PLoS One Research Article BACKGROUND: Antipsychotic medications are increasingly used during pregnancy. Nevertheless, fetal risks are still not fully studied. It is currently unclear whether the antipsychotic treatment might induce a higher risk of fetal death. We aimed to determine if use of antipsychotic medication during pregnancy is associated with an increased risk of spontaneous abortion or stillbirth. METHODS: In a historical cohort study, we identified all clinically recognized pregnancies registered in the nationwide Danish registries from 1997 to 2008 (N = 1,005,319). Exposure was defined as any prescription of antipsychotic medications redeemed by the pregnant women during the exposure window, and recorded in the Danish National Prescription Register. Outcome was defined as any spontaneous abortion or stillbirth recorded in the Danish National Hospital Register and the Danish Medical Birth Register respectively. RESULTS: Women exposed to antipsychotic medications during pregnancy had a 34% higher risk of spontaneous abortion (adjusted relative risk = 1.34; 95% confidence interval = 1.22; 1.46) compared to unexposed women, but a similar risk compared to women exposed prior to (but not during) pregnancy (adjusted relative risk = 1.04; 95% confidence interval = 0.93; 1.17). The risk of spontaneous abortion was not increased in exposed pregnancies when compared to unexposed pregnancies in the same women (adjusted hazard ratio = 1.11; 95% CI = 0.94; 1.31). A twofold higher risk of stillbirth was found in women exposed to antipsychotic medications compared with unexposed women (relative risk = 2.27; 95% confidence interval = 1.45; 3.55) and compared with women exposed only prior to pregnancy (relative risk = 2.06; 95% confidence interval = 1.01; 4.19). CONCLUSIONS: The increased risk of spontaneous abortion found in women treated with antipsychotic medications during pregnancy is most likely due to confounding factors. The risk of stillbirth was twofold higher in pregnancies exposed to antipsychotic medication during pregnancy. Treatment with antipsychotic medications during pregnancy requires careful consideration. Public Library of Science 2015-07-10 /pmc/articles/PMC4498617/ /pubmed/26162087 http://dx.doi.org/10.1371/journal.pone.0132280 Text en © 2015 Sørensen et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Sørensen, Merete Juul Kjaersgaard, Maiken Ina Siegismund Pedersen, Henrik Søndergaard Vestergaard, Mogens Christensen, Jacob Olsen, Jørn Parner, Erik Pedersen, Lars Henning Bech, Bodil Hammer Risk of Fetal Death after Treatment with Antipsychotic Medications during Pregnancy |
title | Risk of Fetal Death after Treatment with Antipsychotic Medications during Pregnancy |
title_full | Risk of Fetal Death after Treatment with Antipsychotic Medications during Pregnancy |
title_fullStr | Risk of Fetal Death after Treatment with Antipsychotic Medications during Pregnancy |
title_full_unstemmed | Risk of Fetal Death after Treatment with Antipsychotic Medications during Pregnancy |
title_short | Risk of Fetal Death after Treatment with Antipsychotic Medications during Pregnancy |
title_sort | risk of fetal death after treatment with antipsychotic medications during pregnancy |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4498617/ https://www.ncbi.nlm.nih.gov/pubmed/26162087 http://dx.doi.org/10.1371/journal.pone.0132280 |
work_keys_str_mv | AT sørensenmeretejuul riskoffetaldeathaftertreatmentwithantipsychoticmedicationsduringpregnancy AT kjaersgaardmaikeninasiegismund riskoffetaldeathaftertreatmentwithantipsychoticmedicationsduringpregnancy AT pedersenhenriksøndergaard riskoffetaldeathaftertreatmentwithantipsychoticmedicationsduringpregnancy AT vestergaardmogens riskoffetaldeathaftertreatmentwithantipsychoticmedicationsduringpregnancy AT christensenjacob riskoffetaldeathaftertreatmentwithantipsychoticmedicationsduringpregnancy AT olsenjørn riskoffetaldeathaftertreatmentwithantipsychoticmedicationsduringpregnancy AT parnererik riskoffetaldeathaftertreatmentwithantipsychoticmedicationsduringpregnancy AT pedersenlarshenning riskoffetaldeathaftertreatmentwithantipsychoticmedicationsduringpregnancy AT bechbodilhammer riskoffetaldeathaftertreatmentwithantipsychoticmedicationsduringpregnancy |